Optimize Cognitive Assessment with Digital Endpoints from Cogstate
Conventional paper-and-pencil cognitive assessments are often error-prone, lengthy, and require highly trained neuropsychologists for appropriate administration. This increases study costs, complicates outcome measurement, and heightens burden on patients and sites.
Cogstate’s digital cognitive assessments offer solutions to these operational challenges:
- Automated administration, suitable for remote testing
- Brief, easing burden on patients and increasing completion rates
- Automatically scored with immediate access to results
- Culture-neutral and not limited by a subject’s level of education
- Suitable for repeated administration
Cogstate assessments are sensitive to changes in pediatric and adult oncology patients and designed and validated to assess specific domains affected by cancer—such as attention, memory, and executive function. They’ve been leveraged to measure cognition in patients receiving a range of treatments including radiation and chemotherapy and used in all phases of drug trials.
The use of appropriately sensitive and domain specific cognitive assessments is important to the measurement of relevant changes in cognition in studies of oncology. It is important to note that neurologic exams and global instruments such as the MMSE are recognized as deficient in this respect. (J. Wefel, MD Anderson Cancer Center)
